© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
April 09, 2021
Robert Dreicer, MD, discusses the optimal use of checkpoint inhibitors in urothelial carcinoma.
March 03, 2021
December 04, 2020
Firas El Chaer, MD, discusses the role of next-generation sequencing (NGS) in myeloproliferative neoplasms.
November 25, 2020
Firas El Chaer, MD, discusses the potential utility of combination strategies with ruxolitinib in patients with myeloproliferative neoplasms.
November 19, 2020
Emily C. Ayers, MD, discusses recent developments in chronic lymphocytic leukemia.
Kirsten L. Greene, MD, MAS, FACS, discusses the future of personalized therapy in prostate cancer.